Equity Details
Price & Market Data
Price: $23.03
Daily Change: -$1.33 / 5.78%
Daily Range: $22.01 - $24.95
Market Cap: $1,392,401,152
Daily Volume: 528,493
Performance Metrics
1 Week: -7.16%
1 Month: -12.64%
3 Months: 7.30%
6 Months: 366.5%
1 Year: 733.6%
YTD: 0.35%
About Damora Therapeutics, Inc. (DMRA)
Essential market overview for Damora Therapeutics, Inc. (DMRA). Current price: 23.03, daily change: -$1.33 / 5.78%. Market cap: 1,392,401,152. All key performance metrics for a full analysis.
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company's lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.